Forward BIOLABS is thrilled to announce the launch of Forward Memberships, a new initiative made possible by a grant from the Wisconsin Economic Development Corporation. Forward Memberships will enable promising Biohealth entrepreneurs, including those from underrepresented groups, to advance their research and bring their innovations...
The Wisconsin Technology Council reports early-stage businesses in the state last year raised about $490 million through 107 deals, well below the two previous years....
This novel project, “Radiomic spatial maps for identifying viable tumor extent on multi-parametric MRI for Glioblastoma,” will be the first to utilize artificial intelligence (AI) to detect hard-to-see glioblastoma tumor edges during a clinical trial....
The WIA is thrilled to announce the 31 finalists for the 2024 awards, recognizing the state’s most innovative and forward-thinking companies and individuals....
A fusion device at the University of Wisconsin–Madison generated plasma for the first time Monday, opening a door to making the highly anticipated, carbon-free energy source a reality....
The Center for Human Genomics and Precision Medicine advances the use of an individual’s genetic information to optimize and guide health care decisions including diagnosis and treatment....
Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded a total of $1.5 million to 28 organizations through its Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) Program. Grant recipients are committed to improving colorectal cancer (CRC) screening...
For the 13th consecutive year, U.S. News & World Report ranked University of Wisconsin Hospitals No. 1 in Wisconsin on its Best Hospitals list....
Lynda S. Bader is the director of clinical trials strategic initiatives for the UW Clinical Trials Institute (CTI). She was recently honored with a Regents Academic Staff Excellence Award, the highest recognition bestowed by the Universities of Wisconsin, for her leadership of strategic initiatives that...
Toxoplasma gondii is a parasite responsible for toxoplasmosis, a lifelong chronic infection prevalent in about 30% of the human population. It poses little harm to healthy individuals but can result in severe consequences for immunocompromised people. There is currently no vaccine for Toxoplasma infection, and...